Funded Research

Validating Extracellular Vesicle–Associated Biomarkers as an Early Diagnostic and Therapeutic Target in Parkinson’s Disease

This project is one of six projects supported through the 2026 Advancing Groundbreaking Research in Alzheimer’s and Parkinson’s Diseases – Team Award. Meet the research team members. 
 
This funding opportunity is made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) and the Brain Canada Foundation, in partnership with the Alzheimer Society of BC and Yukon, Branch Out Neurological Foundation, CLEAR Foundation, Health Research BC, Pacific Parkinson’s Research Institute, Parkinson Society BC, and the Patrick & Dulcie Lenox Endowment. 


Project summary

This BC-based project is led by the University of British Columbia. It includes international collaboration and uses samples and data from a large international Parkinson’s disease study. Parkinson’s disease is often diagnosed only after movement problems appear. By then, some permanent damage to brain cells may have already occurred. There is no reliable blood test that can detect the disease early or show how it is changing over time. Some people have rapid eye movement sleep behaviour disorder, which can cause movement or talking during dreams. Many later develop Parkinson’s disease or a related condition, so this group may offer an important opportunity for earlier detection.

Our team will study extracellular vesicles, tiny particles in the blood that carry proteins and other biological information. Our early findings suggest that vesicles linked to red blood cells contain higher levels of a protein called alpha-1 antichymotrypsin, or ACT, in people with Parkinson’s disease. Higher ACT levels also appear to be related to more severe symptoms.

We will test whether this marker can track disease progression, develop a practical blood test, and study whether lowering ACT reduces Parkinson’s-related changes in laboratory models. We will also look for blood markers that may help identify people with sleep behaviour disorder who are at greater risk.

People with lived experience will help guide the project through advisory meetings and workshops. They will provide input on research priorities, study design, interpretation of results, and how sensitive information about disease risk should be communicated. They will also help prepare public summaries, educational materials, webinars, and outreach activities.

The project may support earlier and more objective monitoring, improve clinical trial design, and open new directions for treatment research. It will also train three doctoral students in biomarker research, diagnostic development, data analysis, drug delivery, and patient-oriented research.

Keywords: Parkinson’s disease; rapid eye movement sleep behaviour disorder; extracellular vesicles; blood-based biomarkers; early detection; disease monitoring; patient-oriented research 

Team members

Shyh-Dar Li

Role: Principal Investigator

Department: Department of Medicine

Position: Tong Louie Chair Professor in Pharmaceutical Sciences

Silke Appel-Cresswell 

Role: Co-Lead

Department: Medicine/Neurology

Position: Marg Meikle Associate Professor in Parkinson’s Research 

Lucas Zhang

Role: Trainee

Department: Faculty of Pharmaceutical Sciences 

Position: PhD Student

Russ Algar 

Role: Co-Lead

Department: Faculty of Chemistry

Position: Professor

Hao-Yuan Hung

Role: Co-Lead

Department: Faculty of Pharmaceutical Sciences 

Position: Visiting Professor

Sam Fereshtehnejad 

Role: Co-Lead

Department: Pacific Parkinson’s Research Centre

Position: Assistant Professor

Sherry Wu

Role: Trainee

Department: Faculty of Chemistry 

Position: PhD Candidate

Letong Wang 

Role: Trainee

Department: Faculty of Pharmaceutical Sciences

Position: PhD Student

Karla Williams

Role: Co-Lead

Department: Faculty of Pharmaceutical Sciences 

Position: Associate Professor and Canada Research Chair

Jacquelyn Cragg

Role: Co-Lead

Department: Faculty of Pharmaceutical Sciences

Position: Associate Professor and Canada Research Chair In Open Science and Epidemiology

Building research careers

Since 2001, we’ve supported over 3,000 BC health researchers to launch programs, drive innovations, and attract millions in new research investment.

View all funded research

Funded research